product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
ATGL (30A4) Rabbit mAb
catalog :
2439
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
30A4
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, immunohistochemistry - paraffin section
more info or order :
citations: 22
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| |
| |
| |
| |
| Peng Y, Miao H, Wu S, Yang W, Zhang Y, Xie G, et al. ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2. Autophagy. 2016;12:2167-2182 pubmed
|
| |
| |
| |
| |
| |
| Turnbull P, Ramos S, Macpherson R, Roy B, Peters S. Characterization of lipolytic inhibitor G(0)/G(1) switch gene-2 protein (G0S2) expression in male Sprague-Dawley rat skeletal muscle compared to relative content of adipose triglyceride lipase (ATGL) and comparitive gene identification-58 (CGI-58). PLoS ONE. 2015;10:e0120136 pubmed publisher
|
| |
| |
| |
| |
| |
| |
product information
SKU :
2439S
Product-Name :
ATGL (30A4) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
M
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Metabolism
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
54
Host :
Rabbit
Target :
ATGL
Primary-Protein :
PNPLA2
Alt-Names :
1110001C14Rik,ATGL,Adipose triglyceride lipase,Calcium-independent phospholipase A2,DKFZp667M109,Desnutrin,FP17548,IPLA2-zeta,PEDF-R,PLPL2,PNPLA2,Patatin-like phospholipase domain-containing protein 2,Pigment epithelium-derived factor,TTS-2.2,TTS2,TTS2.2,Transport-secretion protein 2,patatin-like phospholipase domain containing 2,transport-secretion protein 2.2,triglyceride hydrolase
more info or order :
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.
review
related products
browse more products
questions and comments